scispace - formally typeset
C

Chiara De Nuccio

Researcher at Istituto Superiore di Sanità

Publications -  30
Citations -  849

Chiara De Nuccio is an academic researcher from Istituto Superiore di Sanità. The author has contributed to research in topics: Peroxisome proliferator-activated receptor & Neuroprotection. The author has an hindex of 15, co-authored 27 publications receiving 666 citations.

Papers
More filters
Journal ArticleDOI

Branched-chain amino acids influence the immune properties of microglial cells and their responsiveness to pro-inflammatory signals.

TL;DR: The effects of BCAAs on microglia, the main immune cells of the brain, are evaluated and it is suggested that an intermediate M1/M2 phenotype might result in a less efficient microglial response, which would promote the establishment of a low grade chronic inflammation and increase the likelihood of neurodegeneration.
Journal ArticleDOI

TGF-β and LPS modulate ADP-induced migration of microglial cells through P2Y1 and P2Y12 receptor expression

TL;DR: In this paper, the effects of interferon-gamma, lipopolysaccharide (LPS) or transforming growth factor-β (TGF-β) addition to mixed glial cell cultures, on microglial migration in response to ADP, P2Y12 and p2Y1 mRNA expression as well as on the expression of an array of genes associated with the process of micro-glial activation were investigated.
Journal ArticleDOI

Triazine compounds as antagonists at Bv8-prokineticin receptors.

TL;DR: A new synthesis of some 1,3,5-triazin-4,6-diones as potential non peptidic prokineticin receptor antagonists are approached, containing the following substitutions: N(1), N(5), and C(2) can link an amino-ethyl-guanidine or an ethylendiamine or a 4-ethylbenzyl.
Journal ArticleDOI

Curcumin protects against NMDA-induced toxicity: a possible role for NR2A subunit.

TL;DR: The results of this study confirm the neuroprotective activity of curcumin against NMDA toxicity, possibly related to an increased level of NR2A, and encourage further studies for a possible therapeutic use ofCurcumin based on neuromodulation of NMDArs.